{ "schema_version": "0.1.0", "id": "fda-drug-shortage:lisdexamfetamine-dimesylate-capsule", "slug": "lisdexamfetamine-dimesylate-capsule", "title": "FDA shortage status: Lisdexamfetamine Dimesylate Capsule", "ingredient": "Lisdexamfetamine Dimesylate Capsule", "status": "current", "source_statuses": [ "Current" ], "brand_names": [ "LISDEXAMFETAMINE DIMESYLATE", "VYVANSE" ], "therapeutic_categories": [ "Psychiatry" ], "dosage_forms": [ "Capsule" ], "routes": [ "ORAL" ], "package_count": 90, "packages": [ { "package_ndc": "47781-562-01", "product_ndc": "47781-562", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-563-01", "product_ndc": "47781-562", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-564-01", "product_ndc": "47781-562", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-565-01", "product_ndc": "47781-562", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-566-01", "product_ndc": "47781-562", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-567-01", "product_ndc": "47781-562", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "47781-568-01", "product_ndc": "47781-562", "company_name": "Alvogen", "manufacturer_name": "Alvogen Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "65162-023-09", "product_ndc": "65162-023", "company_name": "Amneal Pharmaceuticals", "manufacturer_name": "Amneal Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "65162-024-09", "product_ndc": "65162-023", "company_name": "Amneal Pharmaceuticals", "manufacturer_name": "Amneal Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "65162-025-09", "product_ndc": "65162-023", "company_name": "Amneal Pharmaceuticals", "manufacturer_name": "Amneal Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "65162-026-09", "product_ndc": "65162-023", "company_name": "Amneal Pharmaceuticals", "manufacturer_name": "Amneal Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "65162-027-09", "product_ndc": "65162-023", "company_name": "Amneal Pharmaceuticals", "manufacturer_name": "Amneal Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "65162-028-09", "product_ndc": "65162-023", "company_name": "Amneal Pharmaceuticals", "manufacturer_name": "Amneal Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "60505-4739-1", "product_ndc": "60505-4739", "company_name": "Apotex Corp.", "manufacturer_name": "Apotex Corp.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "11/01/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "60505-4740-1", "product_ndc": "60505-4739", "company_name": "Apotex Corp.", "manufacturer_name": "Apotex Corp.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "11/01/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "60505-4741-1", "product_ndc": "60505-4739", "company_name": "Apotex Corp.", "manufacturer_name": "Apotex Corp.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "11/01/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "60505-4742-1", "product_ndc": "60505-4739", "company_name": "Apotex Corp.", "manufacturer_name": "Apotex Corp.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1)", "availability": "Unavailable", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "11/01/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "60505-4743-1", "product_ndc": "60505-4739", "company_name": "Apotex Corp.", "manufacturer_name": "Apotex Corp.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)", "availability": "Unavailable", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "11/01/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "60505-4744-1", "product_ndc": "60505-4739", "company_name": "Apotex Corp.", "manufacturer_name": "Apotex Corp.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "11/01/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "60505-4745-1", "product_ndc": "60505-4739", "company_name": "Apotex Corp.", "manufacturer_name": "Apotex Corp.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/04/2026", "initial_posting_date": "11/01/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-550-01", "product_ndc": "64850-550", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-551-01", "product_ndc": "64850-550", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-552-01", "product_ndc": "64850-550", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-553-01", "product_ndc": "64850-550", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-554-01", "product_ndc": "64850-550", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-555-01", "product_ndc": "64850-550", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "64850-556-01", "product_ndc": "64850-550", "company_name": "Elite Laboratories, Inc.", "manufacturer_name": "Elite Laboratories, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0054-0660-25", "product_ndc": "0054-0370", "company_name": "Hikma Pharmaceuticals USA, Inc.", "manufacturer_name": "Hikma Pharmaceuticals USA Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "05/12/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0054-0370-25", "product_ndc": "0054-0370", "company_name": "Hikma Pharmaceuticals USA, Inc.", "manufacturer_name": "Hikma Pharmaceuticals USA Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/13/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0054-0371-25", "product_ndc": "0054-0370", "company_name": "Hikma Pharmaceuticals USA, Inc.", "manufacturer_name": "Hikma Pharmaceuticals USA Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/13/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0054-0372-25", "product_ndc": "0054-0370", "company_name": "Hikma Pharmaceuticals USA, Inc.", "manufacturer_name": "Hikma Pharmaceuticals USA Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/13/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0054-0373-25", "product_ndc": "0054-0370", "company_name": "Hikma Pharmaceuticals USA, Inc.", "manufacturer_name": "Hikma Pharmaceuticals USA Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/13/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0054-0374-25", "product_ndc": "0054-0370", "company_name": "Hikma Pharmaceuticals USA, Inc.", "manufacturer_name": "Hikma Pharmaceuticals USA Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/13/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0054-0375-25", "product_ndc": "0054-0370", "company_name": "Hikma Pharmaceuticals USA, Inc.", "manufacturer_name": "Hikma Pharmaceuticals USA Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/13/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-4661-37", "product_ndc": "0527-4661", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-4662-37", "product_ndc": "0527-4661", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-4663-37", "product_ndc": "0527-4661", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-4664-37", "product_ndc": "0527-4661", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-4665-37", "product_ndc": "0527-4661", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-4666-37", "product_ndc": "0527-4661", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "09/20/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0527-4667-37", "product_ndc": "0527-4661", "company_name": "Lannett Company, Inc.", "manufacturer_name": "Lannett Company, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/18/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0378-6854-77", "product_ndc": "0378-6854", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "manufacturer_name": "Mylan Pharmaceuticals Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0378-6855-77", "product_ndc": "0378-6854", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "manufacturer_name": "Mylan Pharmaceuticals Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0378-6856-77", "product_ndc": "0378-6854", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "manufacturer_name": "Mylan Pharmaceuticals Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0378-6857-77", "product_ndc": "0378-6854", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "manufacturer_name": "Mylan Pharmaceuticals Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0378-6858-77", "product_ndc": "0378-6854", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "manufacturer_name": "Mylan Pharmaceuticals Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0378-6859-77", "product_ndc": "0378-6854", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "manufacturer_name": "Mylan Pharmaceuticals Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0378-6860-77", "product_ndc": "0378-6854", "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company", "manufacturer_name": "Mylan Pharmaceuticals Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42858-161-01", "product_ndc": "42858-161", "company_name": "Rhodes Pharmaceuticals L.P.", "manufacturer_name": "Rhodes Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/24/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42858-162-01", "product_ndc": "42858-161", "company_name": "Rhodes Pharmaceuticals L.P.", "manufacturer_name": "Rhodes Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/24/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42858-163-01", "product_ndc": "42858-161", "company_name": "Rhodes Pharmaceuticals L.P.", "manufacturer_name": "Rhodes Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/24/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42858-164-01", "product_ndc": "42858-161", "company_name": "Rhodes Pharmaceuticals L.P.", "manufacturer_name": "Rhodes Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/24/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42858-165-01", "product_ndc": "42858-161", "company_name": "Rhodes Pharmaceuticals L.P.", "manufacturer_name": "Rhodes Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/24/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42858-166-01", "product_ndc": "42858-161", "company_name": "Rhodes Pharmaceuticals L.P.", "manufacturer_name": "Rhodes Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/24/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "42858-167-01", "product_ndc": "42858-161", "company_name": "Rhodes Pharmaceuticals L.P.", "manufacturer_name": "Rhodes Pharmaceuticals LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/24/2026", "initial_posting_date": "01/11/2024", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "43547-602-10", "product_ndc": "43547-602", "company_name": "Solco Healthcare US, LLC", "manufacturer_name": "Solco Healthcare US,LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/29/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "43547-603-10", "product_ndc": "43547-602", "company_name": "Solco Healthcare US, LLC", "manufacturer_name": "Solco Healthcare US,LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/29/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "43547-604-10", "product_ndc": "43547-602", "company_name": "Solco Healthcare US, LLC", "manufacturer_name": "Solco Healthcare US,LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/29/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "43547-605-10", "product_ndc": "43547-602", "company_name": "Solco Healthcare US, LLC", "manufacturer_name": "Solco Healthcare US,LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/29/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "43547-606-10", "product_ndc": "43547-602", "company_name": "Solco Healthcare US, LLC", "manufacturer_name": "Solco Healthcare US,LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/29/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "43547-607-10", "product_ndc": "43547-602", "company_name": "Solco Healthcare US, LLC", "manufacturer_name": "Solco Healthcare US,LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/29/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "43547-608-10", "product_ndc": "43547-602", "company_name": "Solco Healthcare US, LLC", "manufacturer_name": "Solco Healthcare US,LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/29/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-5111-01", "product_ndc": "0406-5111", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-5112-01", "product_ndc": "0406-5111", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-5113-01", "product_ndc": "0406-5111", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-5114-01", "product_ndc": "0406-5111", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-5115-01", "product_ndc": "0406-5111", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-5116-01", "product_ndc": "0406-5111", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0406-5117-01", "product_ndc": "0406-5111", "company_name": "SpecGx LLC", "manufacturer_name": "SpecGx LLC", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/20/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57664-046-88", "product_ndc": "57664-046", "company_name": "Sun Pharmaceutical Industries, Inc.", "manufacturer_name": "Sun Pharmaceutical Industries, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57664-048-88", "product_ndc": "57664-046", "company_name": "Sun Pharmaceutical Industries, Inc.", "manufacturer_name": "Sun Pharmaceutical Industries, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-048-88)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57664-048-88", "product_ndc": "57664-046", "company_name": "Sun Pharmaceutical Industries, Inc.", "manufacturer_name": "Sun Pharmaceutical Industries, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-048-88)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57664-049-88", "product_ndc": "57664-046", "company_name": "Sun Pharmaceutical Industries, Inc.", "manufacturer_name": "Sun Pharmaceutical Industries, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57664-050-88", "product_ndc": "57664-046", "company_name": "Sun Pharmaceutical Industries, Inc.", "manufacturer_name": "Sun Pharmaceutical Industries, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57664-051-88", "product_ndc": "57664-046", "company_name": "Sun Pharmaceutical Industries, Inc.", "manufacturer_name": "Sun Pharmaceutical Industries, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "57664-052-88", "product_ndc": "57664-046", "company_name": "Sun Pharmaceutical Industries, Inc.", "manufacturer_name": "Sun Pharmaceutical Industries, Inc.", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88)", "availability": "Limited Availability", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "08/05/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "59417-101-10", "product_ndc": "59417-101", "company_name": "Takeda Pharmaceuticals USA Inc.", "manufacturer_name": "Takeda Pharmaceuticals America, Inc.", "presentation": "Vyvanse, Capsule, 10 mg (NDC 59417-101-10)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/23/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "59417-102-10", "product_ndc": "59417-101", "company_name": "Takeda Pharmaceuticals USA Inc.", "manufacturer_name": "Takeda Pharmaceuticals America, Inc.", "presentation": "Vyvanse, Capsule, 20 mg (NDC 59417-102-10)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/23/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "59417-103-10", "product_ndc": "59417-101", "company_name": "Takeda Pharmaceuticals USA Inc.", "manufacturer_name": "Takeda Pharmaceuticals America, Inc.", "presentation": "Vyvanse, Capsule, 30 mg (NDC 59417-103-10)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/23/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "59417-104-10", "product_ndc": "59417-101", "company_name": "Takeda Pharmaceuticals USA Inc.", "manufacturer_name": "Takeda Pharmaceuticals America, Inc.", "presentation": "Vyvanse, Capsule, 40 mg (NDC 59417-104-10)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/23/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "59417-105-10", "product_ndc": "59417-101", "company_name": "Takeda Pharmaceuticals USA Inc.", "manufacturer_name": "Takeda Pharmaceuticals America, Inc.", "presentation": "Vyvanse, Capsule, 50 mg (NDC 59417-105-10)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/23/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "59417-106-10", "product_ndc": "59417-101", "company_name": "Takeda Pharmaceuticals USA Inc.", "manufacturer_name": "Takeda Pharmaceuticals America, Inc.", "presentation": "Vyvanse, Capsule, 60 mg (NDC 59417-106-10)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/23/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "59417-107-10", "product_ndc": "59417-101", "company_name": "Takeda Pharmaceuticals USA Inc.", "manufacturer_name": "Takeda Pharmaceuticals America, Inc.", "presentation": "Vyvanse, Capsule, 70 mg (NDC 59417-107-10)", "availability": "Available", "dosage_form": "Capsule", "routes": [ "ORAL" ], "update_date": "06/23/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0480-3565-01", "product_ndc": null, "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": null, "presentation": "Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0480-3566-01", "product_ndc": null, "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": null, "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0480-3567-01", "product_ndc": null, "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": null, "presentation": "Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0480-3568-01", "product_ndc": null, "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": null, "presentation": "Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0480-3569-01", "product_ndc": null, "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": null, "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0480-3570-01", "product_ndc": null, "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": null, "presentation": "Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" }, { "package_ndc": "0480-3564-01", "product_ndc": null, "company_name": "Teva Pharmaceuticals USA, Inc.", "manufacturer_name": null, "presentation": "Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01)", "availability": "Available", "dosage_form": "Capsule", "routes": [], "update_date": "08/17/2026", "initial_posting_date": "07/14/2023", "source_url": "https://api.fda.gov/drug/shortages.json" } ], "availability_counts": { "Available": 54, "Limited Availability": 34, "Unavailable": 2 }, "initial_posting_date": "01/11/2024", "latest_source_update": "08/20/2026", "source_updated_at": "2026-08-22", "official_url": "https://api.fda.gov/drug/shortages.json", "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages", "source_license_url": "https://open.fda.gov/license/", "retrieved_at": "2026-08-22T15:54:11+00:00", "unknowns": { "local_availability": "Unknown. FDA status is nationwide and is not local inventory.", "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.", "resolution_date": "Unknown unless an FDA source row provides an update date." }, "derivations": { "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.", "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.", "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply." } }